HealthData.Gov
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study
Background 5-fluorouracil remains the standard therapy for patients with advanced/metastatic colorectal cancer. Pre-clinical studies have demonstrated the biological modulation of 5-fluorouracil by methotrexate and…
- HTML
Updated Oct 29, 2026